Drug Trial Radar · NCT02117401
A Prospective, Multi-center, Randomized Controlled Study of Muscle Relaxation Effect and Safety of Mivacurium Chloride in Pediatric Surgery Patients
Last checked: Nov 19, 2026Latest source record: Jul 15, 2014 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
1,152
Actual
Start
Jan 2012
Primary completion
Jun 2013
Study completion Jun 2013
Sponsor
- Lead sponsor
- Jiangsu Nhwa Pharmaceutical Co., Ltd.Industry
- Sponsor type
- Industry
- First posted
- Apr 21, 2014
Design
- Study type
- Interventional
- Phase
- Phase 4
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Double (participant, investigator)
- Primary purpose
- Treatment
- Who can join
- All sexes, from 2 months, up to 14 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
To evaluate the effect and safety of mivacurium chloride in pediatric patients.
Conditions
- Efficacy and Safety of Mivacurium Chloride for Pediatric Patients
Interventions
mivacurium chlorideDrug
intravenously injected during induction with the dose according to allocated group, and intravenously injected with the dose of 0.1 mg/kg when T1 recovers to 25% during period of maintenance.
midazolamDrug
Before induction: after moving into operating room, oral administration with dose of 0.5 mg/kg or mixed with ketamine (midazolam 10 mg+ ketamine 100 mg) with dose of 0.1 ml/kg by intramuscular route for uncooperative children Induction: for children who didn't receive mixture of midazolam and ketamine before induction, it will be given with the dose of 0.05 ml/kg
ketamineDrug
mixed with ketamine (midazolam 10 mg+ ketamine 100 mg) with dose of 0.1 ml/kg by intramuscular route for uncooperative children Induction: for children who didn't receive mixture of midazolam and ketamine before induction, it will be given with the dose of 0.05 ml/kg
propofolDrug
Induction: 2 to 3 mg/kg Maintenance: 50 to 100 mcg/kg/min
RemifentanilDrug
Induction: 2 mcg/kg Maintenance: 0.1 to 0.3 mcg/kg/min
Primary outcomes
What the sponsor says the trial is designed to measure.
- intubation scoreTime frame: 1 minute within intubation
- muscle relaxation effectTime frame: from baseline to no more than 120 minutes after intubation
Locations
No sites are listed on the registry yet.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.